CNBX Pharmaceuticals Inc. (CNBX) Accounts Payables (2011 - 2026)
CNBX Pharmaceuticals' (CNBX) quarterly Accounts Payables came in at $45228.0 in Q2 2026, up 9.67% YoY from $41239.0 in Q2 2025, and up 3.9% on a QoQ basis from $43530.0 in Q1 2026.
CNBX Pharmaceuticals Inc. (CNBX) Accounts Payables (2011 - 2026) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 16 years of Accounts Payables data on file, last reported at $45228.0 in Q2 2026.
- Quarterly Accounts Payables rose 9.67% year-over-year to $45228.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $45228.0 (up 9.67% YoY) and the FY2025 annual result came in at $49252.0, up 20.59% from the prior year.
- Accounts Payables grew to $45228.0 in Q2 2026, from $43530.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $1.0 million in Q2 2023 to a low of $40841.0 in Q3 2024.
- A 5-year average of $246562.4 and a median of $210599.5 in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables soared 217.67% — and 2024, when it sank 87.84%.
- Tracing CNBX's Accounts Payables over 5 years: stood at $596913.0 in 2022, then tumbled by 58.84% to $245712.0 in 2023, then sank by 78.84% to $51992.0 in 2024, then fell by 12.23% to $45631.0 in 2025, then slipped by 0.88% to $45228.0 in 2026.
- The last three Accounts Payables figures came in at $45228.0 (Q2 2026), $43530.0 (Q1 2026), and $45631.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 45,228.00 |
| Feb 28, 2026 | 43,530.00 |
| Nov 30, 2025 | 45,631.00 |
| Aug 31, 2025 | 49,252.00 |
| May 31, 2025 | 41,239.00 |
| Feb 28, 2025 | 62,943.00 |
| Nov 30, 2024 | 51,992.00 |
| Aug 31, 2024 | 40,841.00 |
| May 31, 2024 | 189,820.00 |
| Feb 29, 2024 | 231,379.00 |
| Nov 30, 2023 | 245,712.00 |
| Aug 31, 2023 | 335,915.00 |
| May 31, 2023 | 1.02 Mn |
| Feb 28, 2023 | 424,580.00 |
| Nov 30, 2022 | 596,913.00 |
| Aug 31, 2022 | 461,128.00 |
| May 31, 2022 | 319,588.00 |
| Feb 28, 2022 | 237,193.00 |
| Nov 30, 2021 | 200,449.00 |
| Aug 31, 2021 | 177,505.00 |